Chi-Tai Yeh Selected Research

human MIRN497 microRNA

6/2022

Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-Tai Yeh Research Topics

Disease

85	Neoplasms (Cancer) 04/2024 - 03/2005
20	Neoplasm Metastasis (Metastasis) 09/2023 - 05/2012
19	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 03/2005
13	Carcinogenesis 05/2023 - 07/2012
13	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2007
10	Squamous Cell Carcinoma of Head and Neck 04/2024 - 11/2015
9	Lung Neoplasms (Lung Cancer) 09/2023 - 12/2012
9	Glioblastoma (Glioblastoma Multiforme) 04/2023 - 01/2015
8	Inflammation (Inflammations) 03/2024 - 11/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2013
6	Body Weight (Weight, Body) 05/2023 - 06/2004
6	Glioma (Gliomas) 06/2022 - 01/2015
5	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 05/2012
5	Triple Negative Breast Neoplasms 01/2021 - 06/2015
5	Mouth Neoplasms (Oral Cancer) 07/2018 - 01/2013
3	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 03/2023
3	Osteoarthritis 03/2024 - 10/2021
3	Liver Neoplasms (Liver Cancer) 07/2023 - 01/2018
3	Disease Progression 09/2021 - 02/2016
3	Hypoxia (Hypoxemia) 08/2021 - 01/2017
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 11/2009
3	Ovarian Neoplasms (Ovarian Cancer) 05/2017 - 05/2015
2	Leukemia 01/2023 - 07/2012
2	Virus Diseases (Viral Diseases) 11/2022 - 06/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2018
2	Necrosis 01/2022 - 10/2005
2	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2022 - 01/2018
2	Prostatic Neoplasms (Prostate Cancer) 09/2021 - 01/2021
2	Myocardial Infarction 03/2021 - 01/2020
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Adenocarcinoma 01/2020 - 10/2005
2	Syndrome (Syndromes) 09/2019 - 07/2019
2	Adenocarcinoma of Lung 01/2018 - 01/2013

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2011
18	CateninsIBA 01/2021 - 01/2011
12	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2013
8	MicroRNAs (MicroRNA)IBA 03/2024 - 07/2013
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2018
6	Sorafenib (BAY 43-9006)FDA Link 05/2023 - 06/2021
6	ovatodiolideIBA 01/2023 - 08/2015
5	Messenger RNA (mRNA)IBA 03/2023 - 01/2012
5	ErbB Receptors (EGF Receptor)IBA 06/2022 - 12/2013
5	Temozolomide (Temodar)FDA LinkGeneric 06/2022 - 01/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 01/2017
5	pterostilbeneIBA 06/2015 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2024 - 11/2007
4	Histone DemethylasesIBA 03/2023 - 01/2015
4	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 05/2006
4	Tyrosine Kinase InhibitorsIBA 11/2021 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2018
4	Agammaglobulinaemia Tyrosine KinaseIBA 07/2021 - 05/2015
4	garcinolIBA 03/2021 - 01/2018
4	4-acetylantroquinonol BIBA 01/2021 - 10/2015
4	Caspase 3 (Caspase-3)IBA 01/2020 - 05/2012
4	honokiolIBA 01/2017 - 01/2013
3	Therapeutic UsesIBA 07/2023 - 11/2015
3	PlatinumIBA 03/2023 - 01/2013
3	antrocinIBA 01/2023 - 02/2011
3	AntioxidantsIBA 01/2022 - 06/2005
3	Cadherins (E-Cadherin)IBA 01/2022 - 08/2019
3	VimentinIBA 01/2022 - 08/2019
3	acalabrutinibIBA 08/2021 - 12/2020
3	EnzymesIBA 01/2021 - 06/2005
3	DiterpenesIBA 08/2019 - 01/2018
3	destruxin BIBA 06/2014 - 05/2012
3	cyanidinIBA 03/2012 - 03/2005
3	Gallic AcidIBA 03/2009 - 01/2006
3	p-coumaric acidIBA 03/2009 - 01/2006
3	AcidsIBA 05/2006 - 06/2005
2	notopterolIBA 03/2024 - 05/2023
2	NF-kappa B (NF-kB)IBA 03/2024 - 03/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 10/2021
2	InterleukinsIBA 03/2024 - 07/2019
2	IronIBA 01/2024 - 04/2023
2	Small Interfering RNA (siRNA)IBA 07/2023 - 06/2022
2	Lysine (L-Lysine)FDA Link 03/2023 - 02/2016
2	Beclin-1IBA 02/2023 - 06/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2023 - 06/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2022 - 07/2019
2	Lipoprotein(a)IBA 01/2022 - 03/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 07/2021
2	osimertinibIBA 11/2021 - 07/2021
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2021 - 01/2018
2	Long Noncoding RNAIBA 01/2021 - 02/2016
2	ibrutinibIBA 12/2020 - 05/2015
2	PD 173074IBA 01/2020 - 10/2018
2	Interleukin-10 (Interleukin 10)IBA 09/2019 - 07/2019
2	Polysaccharides (Glycans)IBA 09/2019 - 07/2019
2	Antineoplastic Agents (Antineoplastics)IBA 08/2019 - 08/2015
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2018 - 07/2012
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 07/2012
2	matrigelIBA 01/2017 - 06/2015
2	sulforaphaneIBA 07/2012 - 12/2005
2	JNK Mitogen-Activated Protein KinasesIBA 09/2010 - 03/2005
2	TriterpenesIBA 09/2010 - 11/2009

Therapy/Procedure

25	Therapeutics 12/2023 - 01/2012
10	Drug Therapy (Chemotherapy) 04/2023 - 01/2012
8	Radiotherapy 12/2023 - 01/2012
2	Immunotherapy 04/2024 - 09/2019
2	Aftercare (After-Treatment) 07/2018 - 01/2015